Affiliation:
1. Republican Clinical Hospital for War Veterans of the Ministry of Health of Chuvashia;
I.N. Ulyanov Chuvash State University
2. GAU DPO Institute of Advanced Medical Training
Abstract
Anthropometric data, indicators of laboratory and instrumental examinations were prospectively studied in 80 patients with primary hyperparathyroidism who were treated at the Republican Clinical Hospital for War Veterans of the Ministry of Health of Chuvashia. The quality of life of all patients with primary hyperparathyroidism was assessed before and after surgical treatment using two questionnaires: the SF-36 questionnaire and the standardized quality of life questionnaire for patients with PGPT — PHQol, an adapted Russian version of the quality of life questionnaire for primary hyperparathyroidism. As a result of the study, primary hyperparathyroidism was found to be a disease with a low level of detectability due to low awareness of practitioners, therefore, it often takes up to 10 years from the onset of the disease to diagnosis. It is necessary to introduce screening programs to determine the level of calcium in the blood. The disease primary hyperparathyroidism is of medical and economic importance, which pushes us to pay closer attention to this disease, to create a register of patients with primary hyperparathyroidism. Assessment of the quality of life before and after surgical treatment makes it possible to assess the subjective state of the patient, and also contributes to a patient-oriented approach in the management of patients with PGPT. The standardized questionnaire for assessing the quality of life in hyperparathyroidismPHQoL, its adapted and validated Russian version is a reliable method for studying the quality of life before and after surgical treatment of patients with PGPT, as well as for evaluating the effectiveness of surgical treatment.
Publisher
Endocrinology Research Centre
Reference18 articles.
1. Rossiiskaia assotsiatsiia endokrinologov. Klinicheskie rekomendatsii. Pervichnyi giperparatireoz. Moscow: Ministerstvo zdravookhraneniya RF; 2016. (In Russ.).
2. Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959. doi: https://doi.org/10.1001/jamasurg.2016.2310
3. Mokrysheva NG. Pervichnyi giperparatireoz. Epidemiologiia, klinika, sovremennye printsipy diagnostiki i lecheniia. [dissertation] Moscow; 2011. (In Russ.).
4. Farkhutdinova LM. Pervichnyi giperparatireoz: problemy i puti resheniia. Meditsinskii vestnik Bashkortostana. 2010;5(1):65-70. (In Russ.).
5. Ferraz-de-Souza B. The evolution of primary hyperparathyroidism. Arch Endocrinol Metab. 2015;59(5):381-382. doi: https://doi.org/10.1590/2359-3997000000124